Apple is in the early stages of the development of the computer interfaces that would allow people, especially those who suffer from mobility problems, by controlling iPhone, iPad and Vision Pro devices with nervous signals captured by a new type of brain transplant.
According to Wall Street JournalApple cooperates with Synchron-is a private royal company, based in New York City with the support of Jeff Bezos and Bill Gates-on the project. The industry is expected to grow in the computer, or BCI, significantly over the coming decades. Perhaps the most famous player in space is Elon Musk’s Neuralink, which, as of January, has successfully planted his devices between three people.
Historically, most users relied on both mechanics (by using the keyboard or mouse) and behavior (by using touch or sound screens) with their computers. BCIS eliminates the need for physical movement and expands access to devices for people with deep physical weakness.
Unlike the N1 cultivation of Neuralink, the STNCHron -like system, called STNTRODE, is the top of the brain, not inside, allowing users to avoid the operation of the open gaseous brain transplant. Once applied, Stetrode works using its poles to read the brain signals and translate them into the screen and choose the icon.
Synchron operates with a switch control, which is the prior accessibility feature of the Apple operating system that allows users to control a distance from the Mac remotely with an external air -conditioning device such as the control or switching stick (or now, STENTRODE). Since 2019, Synchron planted Stentrode in 10 people.
the magazine Mark Jackson, a Pittsburgh resident, visited his home because of Als. Test the Jackson Stentrode with Apple Vision Pro. With headphones, he was transferred to Switzerland, where he looked at the edge of the peak of the Alps and felt that his legs were shaking.
Jackson noted that since he cannot use Stetrode to imitate the index’s transfer with a touch or touch screen with his fingers, the movement using Stetrode is much slower than the typical interaction with the computer or smartphone. It is also slower than using a computer with N1 N1, which can capture brain data much more than Synchron, which uses many electrodes more than stintroode.
These recent developments in BCI technology come in anticipation of FDA’s full implant approval, which, as the magazine notes, is not expected for several years.
in press releaseDr. Tom Oxley, CEO and co -founder of Synchron, praised Apple, saying that the company “helps the pioneer of a new interface model, where the brain signals are officially recognized along with touch, sound and writing. With a recognized BCI as an original introduction of apple devices, there are new possibilities for people who live with cheated and analysis.”
https://gizmodo.com/app/uploads/2023/06/9a693a8751707f9ccb45df74a675c504.jpg
Source link